Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Archives of Internal Medicine|January 13, 2006
A double-blind placebo-controlled study of emtricitabine in chronic hepatitis BSeng Gee Lim, Tay Meng Ng, Nelson Kung, et al.
Scientific Reports|May 13, 2021
COVID-19's natural course among ambulatory monitored outpatientsBarbora Weinbergerova, Jiri Mayer, Stepan Hrabovsky, et al.
Journal of Hepatology|August 23, 2016
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised studyScott Fung, Peter Kwan, Milotka Fabri, et al.
Antiviral Research|December 9, 2017
Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countriesHakan Leblebicioglu, Joop E Arends, Resat Ozaras, et al.
Influenza and Other Respiratory Viruses|August 15, 2024
Early COVID-19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023-January 2024Liliana Antunes, Clara Mazagatos, Iván Martínez-Baz, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 19, 2024
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023Liliana Antunes, Clara Mazagatos, Iván Martínez-Baz, et al.
Microorganisms|July 2, 2021
Clinical Characteristics of Patients with Tick-Borne Encephalitis (TBE): A European Multicentre Study from 2010 to 2017Benno Kohlmaier, Nina A Schweintzger, Manfred G Sagmeister, et al.
Influenza and Other Respiratory Viruses|March 9, 2025
Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024Liliana Antunes, Madelyn Rojas-Castro, Marcos Lozano, et al.
Iscience|December 11, 2025
Genome-wide association study identifies <i>ABCG1</i> as a susceptibility locus for tick-borne encephalitisPiyush G Gampawar, Manfred G Sagmeister, Daniel Růžek, et al.
BMC Medicine|November 4, 2025
Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case-control studies, 2015/16-2023/24Angela Mary Catherine Rose, Nathalie Nicolay, Clara Mazagatos, et al.
Pageof 8